152 related articles for article (PubMed ID: 22355234)
21. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
22. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF.
Schuijers J; Mokry M; Hatzis P; Cuppen E; Clevers H
EMBO J; 2014 Jan; 33(2):146-56. PubMed ID: 24413017
[TBL] [Abstract][Full Text] [Related]
23. Comparative integromics on BMP/GDF family.
Katoh Y; Katoh M
Int J Mol Med; 2006 May; 17(5):951-5. PubMed ID: 16596286
[TBL] [Abstract][Full Text] [Related]
24. Analysis of transcriptional regulation of the small leucine rich proteoglycans.
Tasheva ES; Klocke B; Conrad GW
Mol Vis; 2004 Oct; 10():758-72. PubMed ID: 15496828
[TBL] [Abstract][Full Text] [Related]
25. Canonical WNT signaling pathway and human AREG.
Katoh Y; Katoh M
Int J Mol Med; 2006 Jun; 17(6):1163-6. PubMed ID: 16685431
[TBL] [Abstract][Full Text] [Related]
26. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells.
Hatzis P; van der Flier LG; van Driel MA; Guryev V; Nielsen F; Denissov S; Nijman IJ; Koster J; Santo EE; Welboren W; Versteeg R; Cuppen E; van de Wetering M; Clevers H; Stunnenberg HG
Mol Cell Biol; 2008 Apr; 28(8):2732-44. PubMed ID: 18268006
[TBL] [Abstract][Full Text] [Related]
28. SOX transcription factors direct TCF-independent WNT/β-catenin responsive transcription to govern cell fate in human pluripotent stem cells.
Mukherjee S; Luedeke DM; McCoy L; Iwafuchi M; Zorn AM
Cell Rep; 2022 Aug; 40(8):111247. PubMed ID: 36001974
[TBL] [Abstract][Full Text] [Related]
29. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
30. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
[TBL] [Abstract][Full Text] [Related]
31. Highly conserved syntenic blocks at the vertebrate Hox loci and conserved regulatory elements within and outside Hox gene clusters.
Lee AP; Koh EG; Tay A; Brenner S; Venkatesh B
Proc Natl Acad Sci U S A; 2006 May; 103(18):6994-9. PubMed ID: 16636282
[TBL] [Abstract][Full Text] [Related]
32. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
33. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
[TBL] [Abstract][Full Text] [Related]
34. Comparative integromics on FZD7 orthologs: conserved binding sites for PU.1, SP1, CCAAT-box and TCF/LEF/SOX transcription factors within 5'-promoter region of mammalian FZD7 orthologs.
Katoh M; Katoh M
Int J Mol Med; 2007 Mar; 19(3):529-33. PubMed ID: 17273804
[TBL] [Abstract][Full Text] [Related]
35. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
36. Comparative integromics on Ephrin family.
Katoh Y; Katoh M
Oncol Rep; 2006 May; 15(5):1391-5. PubMed ID: 16596216
[TBL] [Abstract][Full Text] [Related]
37. Wnt-promoted Isl1 expression through a novel TCF/LEF1 binding site and H3K9 acetylation in early stages of cardiomyocyte differentiation of P19CL6 cells.
Lu H; Li Y; Wang Y; Liu Y; Wang W; Jia Z; Chen P; Ma K; Zhou C
Mol Cell Biochem; 2014 Jun; 391(1-2):183-92. PubMed ID: 24610003
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.
Weise A; Bruser K; Elfert S; Wallmen B; Wittel Y; Wöhrle S; Hecht A
Nucleic Acids Res; 2010 Apr; 38(6):1964-81. PubMed ID: 20044351
[TBL] [Abstract][Full Text] [Related]
39. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
40. WNT3-WNT14B and WNT3A-WNT14 gene clusters (Review).
Katoh M
Int J Mol Med; 2002 Jun; 9(6):579-84. PubMed ID: 12011973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
